These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30946894)

  • 1. Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin.
    Ibrahim AH; Rosqvist E; Smått JH; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Int J Pharm; 2019 May; 563():217-227. PubMed ID: 30946894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation and optimization of drug-loaded mesoporous silica nanoparticle-based tablets to improve the dissolution rate of the poorly water-soluble drug silymarin.
    Ibrahim AH; Smått JH; Govardhanam NP; Ibrahim HM; Ismael HR; Afouna MI; Samy AM; Rosenholm JM
    Eur J Pharm Sci; 2020 Jan; 142():105103. PubMed ID: 31648050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quercetin-Loaded Mesoporous Silica Nanoparticle-Based Lyophilized Tablets for Enhanced Physicochemical Features and Dissolution Rate: Formulation, Optimization, and In Vitro Evaluation.
    Elmowafy M; Alruwaili NK; Ahmad N; Kassem AM; Ibrahim MF
    AAPS PharmSciTech; 2022 Nov; 24(1):6. PubMed ID: 36447021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of cinnarizine nanosuspensions by particle size engineering: Optimization and physicochemical investigations.
    Mishra B; Sahoo J; Dixit PK
    Mater Sci Eng C Mater Biol Appl; 2016 Jun; 63():62-9. PubMed ID: 27040196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization and evaluation of lyophilized fenofibrate nanoparticles with enhanced oral bioavailability and efficacy.
    Ibrahim AH; Ibrahim HM; Ismael HR; Samy AM
    Pharm Dev Technol; 2018 Apr; 23(4):358-369. PubMed ID: 29069712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of Silymarin nanocrystals lyophilized power applying nanosuspension technology].
    Zhao X; Wang G; Zhang B; Li H; Nie Q; Zang C; Zhao X
    Zhongguo Zhong Yao Za Zhi; 2009 Jun; 34(12):1503-8. PubMed ID: 19777833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
    Gajera BY; Shah DA; Dave RH
    Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
    Nagaraj K; Narendar D; Kishan V
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Optimization of Fast-Disintegrating Tablet Containing Naratriptan Hydrochloride Using D-Optimal Mixture Design.
    Omar SM; AbdAlla FI; Abdelgawad NM
    AAPS PharmSciTech; 2018 Aug; 19(6):2472-2487. PubMed ID: 29869307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
    Kassem MAA; ElMeshad AN; Fares AR
    AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of polyvinyl acetate in an innovative formulation strategy for lyophilized orally disintegrating tablets.
    Vanbillemont B; De Beer T
    Int J Pharm; 2020 Oct; 588():119717. PubMed ID: 32771503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
    Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
    Patel PJ; Gajera BY; Dave RH
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.
    Rahim H; Sadiq A; Ullah R; Bari A; Amin F; Farooq U; Ullah Jan N; Mahmood HM
    Int J Nanomedicine; 2020; 15():8999-9009. PubMed ID: 33235448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and characterization of lumefantrine nanosuspension for enhanced antimalarial activity.
    Shah R; Soni T; Shah U; Suhagia BN; Patel MN; Patel T; Gabr GA; Gorain B; Kesharwani P
    J Biomater Sci Polym Ed; 2021 May; 32(7):833-857. PubMed ID: 33380264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo absorption comparison of nanotechnology-based silybin tablets with its water-soluble derivative.
    Xu D; Ni R; Sun W; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Apr; 41(4):552-9. PubMed ID: 24495272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and optimization of silymarin loaded in lyophilized fast melt tablets to attenuate lung toxicity induced
    Sheta NM; Boshra SA; Mamdouh MA; Abdel-Haleem KM
    Drug Deliv; 2022 Dec; 29(1):1299-1311. PubMed ID: 35470762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryoprotectant choice and analyses of freeze-drying drug suspension of nanoparticles with functional stabilisers.
    Wang L; Ma Y; Gu Y; Liu Y; Zhao J; Yan B; Wang Y
    J Microencapsul; 2018 May; 35(3):241-248. PubMed ID: 29624090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation.
    Sun W; Ni R; Zhang X; Li LC; Mao S
    Drug Dev Ind Pharm; 2015 Jun; 41(6):927-33. PubMed ID: 24785575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of oral lyophilisates containing meloxicam nanocrystals using QbD approach.
    Iurian S; Bogdan C; Tomuță I; Szabó-Révész P; Chvatal A; Leucuța SE; Moldovan M; Ambrus R
    Eur J Pharm Sci; 2017 Jun; 104():356-365. PubMed ID: 28435075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.